Astra Zeneca

Call
Website
35 Gatehouse Dr
Waltham, MA 02451
+1 (781) 839-4000
http://www.mychargepoint.net

Astrazeneca Bos, situated in Waltham, MA, is a leading pharmaceutical company renowned for its innovative contributions to the healthcare industry. Their cutting-edge research and development efforts focus on creating groundbreaking medications to address a wide array of medical conditions, striving to enhance the quality of life for individuals worldwide. At Astrazeneca Bos, a team of dedicated professionals works tirelessly to push the boundaries of science and deliver impactful solutions that benefit patients and healthcare providers alike.

With a commitment to excellence and a passion for scientific advancement, Astrazeneca Bos stands as a beacon of progress in the realm of pharmaceutical innovation. Their state-of-the-art facilities in Waltham, MA serve as the epicenter for transformative research, where brilliant minds collaborate to develop pioneering therapies that shape the future of healthcare. By fostering a culture of exploration and discovery, Astrazeneca Bos remains at the forefront of the pharmaceutical landscape, dedicated to improving health outcomes and driving positive change on a global scale.

Generated using this brand's available information

Also at this address

Own this business?
See a problem?

You might also like

Medical research, Biotherapeutics

Kano Therapeutics Inc

Kano Therapeutics Inc, based in Cambridge, MA, is pioneering advancements in cell therapy through its innovative TFome platform, which leverages cutting-edge technologies in synthetic biology, gene editing, and machine learning. This groundbreaking approach enables the production of induced pluripotent stem cell (iPSC) therapies at a significantly accelerated pace, enhancing efficiency, quality, and accessibility for patients across various therapeutic areas. With a dedicated team of visionary scientists and operators, Kano Therapeutics is focused on developing best-in-class cell therapy programs targeting gastrointestinal, neurological, and immunological diseases. Their commitment to pushing scientific boundaries aims to deliver transformative treatments that can significantly improve patient outcomes. Generated from the website
Drugs and drug proprietaries, Business services, nec, nec

Biogen

1
"Biogen is arguably the fourth best biotech company of all time. And, 3 stars in the pharma world is quite a good rating. But, their recent dabbling in antibodies for CNS disease exposes an..."
Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
United States›Massachusetts›Waltham›Astra Zeneca